DERM · Journey Medical Corp
United States · RS rating 15 · As of 2026-10-14
| Price | 5.28 USD |
|---|---|
| 1-day change | -7.0% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 7 / 14 / 24 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 19 / 37 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +87.5% |
| Sales growth Q/Q | -8.8% |
| Distance from 52-week high | +43.0% |
| Market cap (USD) | $170.6M |